----
Current ValuationThe current P/E ratio is -131.75, below the reasonable range, cheaper than 87.73% of the time in the past 5 years, and the industry ranks 215/223, the industry Median 22.04.
-131.75xP/E
¥23.50Stock price
¥-0.18Earnings per share
-131.75xP/E
Stock price¥23.50Earnings per share¥-0.18
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 11.11x
- Typical range
- -58.24x–46.26x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.04x
015304560
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.04x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
688506SHBIOKIN PHARMACEUTICAL | -79.72x | 15.13% | ¥100.77B |
000661SZCCHT | -67.08x | 588.46% | ¥28.43B |
300255SZCSBIO | -49.96x | -- | ¥17.54B |
688837SHEvopoint | -32.43x | -- | ¥14.70B |
300363SZPorton | -131.75x | 105.56% | ¥12.61B |
300436SZCosunter | -58.01x | -- | ¥12.17B |
300006SZLummy | -87.76x | -- | ¥10.49B |
002099SZHISOAR | -38.24x | -- | ¥8.97B |
000908SZCSPC Jingfeng | -343.05x | -- | ¥8.76B |
688505SHFudan-Zhangjiang | -69.78x | -- | ¥7.19B |
002737SZSFPM | -49.17x | -- | ¥6.92B |
600252SHZhongheng Group | -16.28x | -- | ¥6.81B |
600129SHTAIJI GROUP | -341.17x | 127.27% | ¥6.69B |
600422SHKPC | -23.00x | 90.58% | ¥6.56B |
688176SHAsieris | -11.83x | 1.35% | ¥6.26B |
002424SZGZBL | -47.70x | -- | ¥6.17B |
603229SHAusun Pharm | -1,332.36x | 106.25% | ¥6.04B |
002082SZWBDE | -40.81x | -- | ¥5.98B |
000813SZDEZHAN HEALTHCARE | -15.19x | -- | ¥5.89B |
300267SZER-KANG | -16.94x | -- | ¥5.88B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
